Foot Orthotic Insoles Market Expected to Witness a Sustainable Growth over 2030: Grand View Research Inc.

 Foot Orthotic Insoles Market Growth & Trends

The global foot orthotic insoles market size is expected to reach USD 5.78 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to expand at a CAGR of 6.9% from 2022 to 2030. An increase in the obese and geriatric population is the major factor that drives the growth. A rise in the demand for customized foot orthotic insoles is anticipated to provide ample opportunity for the market over the forecast period. The initial price of buying orthotic insoles is depressing healthcare providers as well as individuals from investing in them which is expected to contract demand. Also, limited awareness across emerging countries is likely to hamper the product’s penetration.

The COVID-19 pandemic has negatively impacted the growth of the foot orthotic insoles industry. Key players observed a drop in revenue in their orthotic business segments during the pandemic. However, the industry observed a resurgence in the sales figures of foot orthotic insoles in 2021. For instance, Hanger Inc. saw a drop in revenues in its business segment during 2020 compared to the same period in 2019. Though, in 2021 the company observed a rise in its revenue. The market is expected to grow considerably over the forecast period.

The thermoplastics segment accounted for the largest revenue share of over 55.0% in 2021. The high adoption of thermoplastic material for the manufacturing of foot orthotic insoles largely reduces plantar pressure. Therefore, this material is the foremost choice for manufacturers owing to its increased benefits. The increase in the implementation of these insoles for sports and athletic activities has surged the demand for effective shock-absorbing insole materials. Therefore, the thermoplastics segment generated large revenue in 2021.

North America acquired the largest revenue share in 2021. The large prevalence of diabetes, an increase in sports activities, and technological developments owing to large investments in R&D drive regional growth. According to estimates released by Milford Podiatry Associates, about 19% of the U.S. population suffers from an average of 1.4-foot problems annually. The increasing prevalence of foot disorders from underlying chronic conditions and external injuries is driving growth in this region.

Major market players include Reckitt Benckiser Group PLC; Hanger Inc.; Ottobock SE & Co. KGaA; Ossur hf; Algeo Limited; Bauerfeind AG; Groupe Gorge; Colfax Corporation; Superfeet Worldwide Inc.; Materialise NV; and Blatchford Group Limited. Several global manufacturers who have core competencies, as well as technical expertise, are taking efforts to manufacture and develop novel products that will attract more customers. Aetrex Worldwide Inc., for instance, manufactures a host of orthotics products that are largely suitable for patients suffering from plantar fasciitis, flat feet, high arches, heel pain, arch, ball of foot discomfort, and foot aches arising from standing professions.

Request a free sample copy or view report summary: Foot Orthotic Insoles Market Report

Foot Orthotic Insoles Market Report Highlights

• Asia Pacific is expected to register the fastest CAGR over the forecast period, attributed to an increasing in investment in health care infrastructure, an increase in disposable income of people, a developing economy, and a large population base with chronic diseases and other foot pain conditions
• The composite carbon fiber segment is likely to grow at the fastest CAGR from 2022 to 2030. Most athletes use these insoles as the material claims to store the energy and direct it toward the ground, surging speed while increasing energy efficiency, thus it is expected to grow at a considerable CAGR over the forecast period
• The prefabricated segment is likely to grow at the fastest CAGR over the forecast period. This is attributed to the rising consumer awareness regarding foot orthotic insoles among people with situations such as plantar fasciitis, and foot arch problems
• The drug stores segment is likely to grow at the fastest CAGR over the forecast period. This is attributed to the rapid expansion of drug stores all around the world, mostly in emerging regions

Access Press Release@ https://www.grandviewresearch.com/press-release/global-foot-orthotic-insoles-market

Foot Orthotic Insoles Market Segmentation

Grand View Research has segmented the global foot orthotic insoles market based on material, type, distribution channel, and region:

Foot Orthotic Insoles Material Outlook (Revenue, USD Million, 2017 - 2030)

• Thermoplastics
• Composite Carbon Fiber
• Others

Foot Orthotic Insoles Type Outlook (Revenue, USD Million, 2017 - 2030)

• Pre-fabricated
• Custom-made

Foot Orthotic Insoles Distribution Channel Outlook (Revenue, USD Million, 2017 - 2030)

• Drug Stores
• Hospitals & Clinics
• Others

Foot Orthotic Insoles Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Malaysia
  • Australia
• Central & South America
  • Brazil
• Middle East & Africa
  • South Africa

List of Key Players in the Foot Orthotic Insoles Market

• Reckitt Benckiser Group PLC
• Hanger Inc.
• Ottobock SE & Co. KGaA
• Össur hf
• Algeo Limited
• Bauerfeind AG
• Groupe Gorge
• Colfax Corporation
• Superfeet Worldwide Inc
• Materialise NV
• Blatchford Group Limited

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Dental Service Organization Market Advanced Technologies and Growth Opportunities Worldwide By 2030

 Dental Service Organization Market Growth & Trends

The global dental service organization market size is expected to reach USD 454.7 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to register a CAGR of 15.8% from 2023 to 2030. Dental service organizations are independent business support owners that provide a dental practice with critical business management and support including non-clinical operations. The services offered by the DSOs include facility maintenance, supply procurement, human resources, compliance, accounting, and marketing services.

DSOs are private equity back entities and are growing significantly as it lowers the burden of administrative work on dental practitioners and helps them to focus more on dental treatments. Key implant manufacturers like Institut Straumann and Dentsply Sirona which capture major market share in the region have undertaken new initiatives like collaborating with dental service organizations for the distribution of dental equipment.

A single DSO represents hundreds of clinics and dentists, including generalists, specialists, and technicians which makes partnerships of implant manufacturers with DSOs more fruitful by providing a consistent flow of orders. As per Harris Williams, an investment banking company in the U.S, the DSO market has room for significant growth globally as the demand for dental treatments is on the rise.

The advent of COVID-19 impacted the dental services market as the pandemic resulted in offices temporarily shutting down practices. However, as per Dental Tribune, many mergers and acquisitions in the DSO market were witnessed post-pandemic and this will help in the market growth during the forecast period.

Request a free sample copy or view report summary: Dental Service Organizations Market Report

Dental Service Organization Market Report Highlights

• The Others segment is projected to dominate the market throughout the forecast period. Services such as leasing, compliance, facility maintenance, technical support, etc play a very crucial role in running a dental practice
• The Medical Supplies procurement service segment is projected to grow fast over the forecast period as It significantly eases the process of supply purchase for a dental practice.
• General Dentists by end-use segment dominated the market owing to the fact that the majority of the general dentists are getting affiliated with the DSOs to provide effective treatment
• North America accounted for the highest share of the dental service organization market due to high awareness of dental treatments and the rise in the number of mergers and acquisitions in the DSO market.
• Asia Pacific is expected to grow at a CAGR of 17.2% owing to the rising awareness and adoption of dental services in Asian countries.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-dental-service-organization-market

Dental Service Organization Market Segmentation

Grand View Research has segmented the global dental service organization market based on services, end-use, and region:

Dental Service Organization By Service Outlook (Revenue, USD Million, 2018 - 2030)

• Human Resources
• Marketing and Branding
• Accounting
• Medical Supplies procurement
• Others

Dental Service Organization End-Use Outlook (Revenue, USD Million, 2018 - 2030)

• Dental surgeons
• Endodontists
• General dentists
• Others

Dental Service Organization Region Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa
  • Saudi Arabia

List of Key Players in Dental Service Organization Market

• Pacific Dental
• Heartland Dental
• Aspen Dental
• DentalCare Alliance
• 42North Dental
• Colosseum Dental Group
• GSD Dental Clinics
• Dentelia
• MB2 DENTAL

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Global Market For Home Textile to Witness Tremendous Growth and Expansion by 2030

 Home Textile Market Growth & Trends

The global home textile market size is expected to reach USD 185.97 billion by 2030, expanding at 5.7% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. The home textile & bedding industry is in a state of flux. Shifting retail models, along with changing consumer preferences, encourages manufacturers to continuously implement new strategies to combat challenges. The overall business arena is undergoing a disruption owing to the rapid adoption of online retailing.

Organic fiber-based materials have witnessed an increased demand over the years. Several consumers have been showing a preference for organic cotton as well as for certifications such as Oeko-Tex, which ensure that no toxic chemicals are used while manufacturing the product. In January 2021, Mitchell Gold + Bob Williams launched its first exclusive bedding line, and the collection comprises of an array of textures and subtle colors. Every piece in the line has Oeko-Tex Certification. Thus, organic and natural products that are eco-friendly, as well as toxin-free, have been gaining traction.

Manufacturers, to produce quality products, have been using the most modern technologies and are thus, continuously updating their manufacturing facilities. The manufacturing of home textile products can be initiated with low-to-medium capital investment and thus, a plethora of manufacturers have entered the picture. With the changes in consumer buying behavior, high-end products have also been experiencing traffic.

The e-commerce market is expected to progress at a faster rate than the offline market in the coming years. The concept of the bed-in-a-box has been gaining popularity among consumers, which is expected to contribute to the growth of online distribution channels over the forecast period. Benefits such as convenient and hassle-free purchasing, free delivery by many companies, and the availability of a wide variety of products to suit everybody’s size and sleeping style have significantly contributed to the popularity of this trend.

Manufacturers and retailers in the industry have been leveraging all consumer touchpoints to move consumers beyond replenishment and inspire them to purchase new products, which has resulted in the collaboration and coordination of hundreds of workers at multiple companies around the globe. This complex and tightly interconnected network can have significant implications on the price, quality, and availability of products that customers ultimately see at the end of the supply chain.

Request a free sample copy or view report summary: Home Textile Market Report

Home Textile Market Report Highlights

• Home textile products, including bed linen, made using natural fabrics have been in demand for a decade now. However, the demand for natural materials has seen significant growth since the pandemic and is expected to increase further in the future. For bed linens, Scandinavian designs in naturally grown fabric materials and stripped-down styles have been trending in 2022. Most designer magazines featuring home decorhighlight Scandinavian influence on bed linens, as they create light-and-bright bedrooms with an airy aesthetic while offering a superior feel and comfort owing to the incorporation of natural fabric
• Shifting retail models along with changing consumer preferences push manufacturers to continuously form new strategies to combat the challenges. Manufacturers have been focusing on automating manufacturing plants and engaging in constant product innovation to launch products that provide better solutions to users
• Companies in the North America home textiles have been implementing various corporate strategies to achieve instant inorganic growth, with partnerships being one of the most vital strategies. For instance, in December 2020, WestPoint Home, Inc., partnered with asthma and allergy expert Robin Wilson to develop bedding and bath collections under the Clean Design Home x Martex brand. The assortment includes sheets, comforters, towels, and utility bedding

Access Press Release@ https://www.grandviewresearch.com/press-release/global-home-textiles-market

Home Textile Market Segmentation

Grand View Research has segmented the global home textile market based on products, material, distribution channel, and region:

Home Textile Product Outlook (Revenue, USD Billion, 2017 - 2030)

• Bedroom Linen
• Bathroom Linen
• Carpets and Floor Coverings
• Kitchen Linen
• Curtains and Drapes

Home Textile Material Outlook (Revenue, USD Billion, 2017 - 2030)

• Polyester
• Cotton
• Silk
• Wool
• Others (hemp, jute, etc.)

Home Textile Distribution Channel Outlook (Revenue, USD Billion, 2017 - 2030)

• Offline
  • Supermarket/ Hypermarket
  • Specialty Stores
  • Others
• Online

Home Textile Regional Outlook (Revenue, USD Billion, 2017 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia & New Zealand
  • South Korea
  • ASEAN
• Central & South America
  • Brazil
  • Argentina
• Middle East & Africa (MEA)
  • South Africa
  • UAE
  • Saudi Arabia

List of Key Players in the Home Textile Market

• Welspun Group
• Springs Global
• New Sega Home Textiles
• Ralph Lauren Corporation
• Shenzhen Fuanna
• Trident Group
• Marvic Textiles
• Shanghai Hometex, Honsun
• Hunan Mendale Hometextile Company Ltd.
• LLC Honsun Home Textile

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Everything As A Service Market is Projected to Boost USD 1,208.5 Billion by 2030: Grand View Research Inc.

 Everything As A Service Market Growth & Trends

The global everything as a service market size is anticipated to reach USD 1,208.5 billion by 2030, registering a CAGR of 22.3% during the forecast period, according to a new study by Grand View Research, Inc. Industry players are poised to emphasize XaaS platforms for increased scalability, security and cost savings. Organizations can reduce costs through the purchase of services on a subscription basis. Furthermore, the rising penetration of cloud computing and the high number of offerings provided by the cloud will bode well for the industry's growth. With a host of companies adopting the XaaS model by way of cloud-based monitoring, industry participants will continue to invest in the business vertical.  

COVID-19 put the spotlight on subscription models as the outbreak brought a paradigm shift through digital transformation. For instance, retailers and other enterprises went online or hybrid, exhibiting an increased demand for the XaaS models. Prominently, XaaS became sought-after to streamline remote-based operations. Moreover, it is worth noting that the prevailing geopolitical situation, including Russia’s invasion of Ukraine and the global supply chain crisis, has had a toll on the global market. However, technological advancements could foster agility, enabling key players to offer enhanced customer experience.

Software as a Service (SaaS) has witnessed significant traction following the penetration of cloud-based apps across developing and developed countries. Furthermore, the increasing footprint of the pay-as-you-go or subscription model has boded well for the stakeholders fostering XaaS market share. End-users are poised to explore opportunities in XaaS to mobilize the workforce seamlessly and access app data from any location. With the pricing model being scalable and flexible, it plays a pivotal role in reducing the capital expenditure needed to establish licenses and infrastructure for the software.

The industry trend also alludes to artificial intelligence (AI), machine learning, and vertical SaaS waves that could create massive value. Many sectors, including healthcare, education, logistics, agriculture, and financial services, have received an uptick from AI-powered solutions. For instance, vertical SaaS has set the trend to boost data governance, customer data, and intelligence plus meet industry requirements. It is worth mentioning that vertical SaaS complements logistics analytics, retail analytics, and healthcare analytics.

From the regional perspective, Europe emerging as a favorable investment hub comes on the back of bullish initiatives from the leading companies. For instance, in March 2022, Amazon contemplated infusing around USD 2.36 billion into the U.K. infrastructure during the next two years. Meanwhile, March 2021 witnessed Hop in raise USD 400.0 million in Series C funding. The company suggested Europe has immense SaaS talent and claimed it had bolstered its portfolio to foster live video collaboration and remote community. Moreover, XaaS models have helped companies across the U.K., France, Germany, and Italy to streamline IT operations and prioritize innovations.

The competitive scenario suggests leading companies could foster their penetration with an emphasis on mergers & acquisitions, product launches, technological advancements, R&D activities, and geographical expansion. For instance, in January 2021, Microsoft Corporation joined hands with Tanla, a software company based in Hyderabad, to roll out a Block chain-enabled communications platform-as-a-service (CPaaS)-Wisely-built on Azure Cloud. Microsoft Corporation and Tanla will reportedly be the co-sell partners for the platform that is believed to provide trusted and secure communication experiences. Leading companies are poised to focus on solidifying their offerings to foster their penetration across untapped areas.

Request a free sample copy or view report summary: Everything As A Service Market Report

Everything As A Service Market Report Highlights

• In terms of type, the Infrastructure-as-a-Service (IaaS) segment could account for a sizable share of the global market due to the optimistic demand from the governments along with small and mid-sized businesses
• For verticals, the BFSI sector will grow on the heels of notable trends in the cloud computing
• North America will propel the Everything as a Service (XaaS) market value with surging demand for smart devices and BYOD trends. Besides, increased adoption of the security as a service (SECaaS) platform will also bode well for the regional outlook
• Leading companies are slated to foster organic and inorganic growth strategies 

Access Press Release@ https://www.grandviewresearch.com/press-release/global-everything-as-a-service-market

Everything As A Service Market Segmentation

Grand View Research has segmented the global everything as a service market based on offering, type, organization size, vertical, and regions:

Everything As A Service Offerings Outlook (Revenue, USD Billion, 2017 - 2030)

• Solutions
• Services

Everything As A Service Type Outlook (Revenue, USD Billion, 2017 - 2030)

• IaaS
• PaaS
• SaaS
• CaaS
• DaaS
• SECaaS
• DRaaS
• Others

Everything As A Service Organization Size Outlook (Revenue; USD Billion, 2017 - 2030)

• SMEs
• Large enterprises

Everything As A Service Verticals Outlook (Revenue, USD Billion, 2017 - 2030)

• BFSI
• IT and Telecom
• Media and Entertainment
• Government
• Healthcare
• Manufacturing
• Oil and Gas
• Energy and Utilities
• Others

Everything As A Service Regional Outlook (Revenue, USD Billion; 2017 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • UK.
  • Germany
  • France
• Asia Pacific
  • China
  • India
  • Japan
• South America
  • Brazil
• Middle East & Africa

List of Key Players of Everything As A Service Market

• Amazon Web Services
• Alibaba Group
• Avaya
• Cisco Systems Inc
• Dell
• Google
• IBM
• Microsoft
• Oracle Corporation
• Rack space
• VMware

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Face Shields Market Size Projected to Rise Lucratively during 2022 to 2030: Grand View Research Inc.

 Face Shields Market Growth & Trends

The global face shields market size is expected to reach USD 1.3 billion by 2030 according to a new report by Grand View Research, Inc., expanding at a CAGR of 7.2% over the forecast period. The market is primarily driven by reasons such as increased awareness as a result of the COVID-19 pandemic, severe rules relating to personnel safety, and rising awareness about industrial occupational risks.

The market has prospered from the Covid-19 pandemic. This is mostly due to an increase in the demand for face shields, which prevent or reduce the spread of life-threatening Covid-19 infections. The expanding number of community-acquired illnesses, particularly respiratory infections, has driven the need for and demand for face shields.

The aging population’s increased health concerns and unhealthy lifestyles are expected to increase the demand for healthcare services. As a result, it is anticipated that demand for medical equipment and supplies will increase throughout the projected period. This in turn has fueled the demand for personal protective equipment, such as face shields.

Rising healthcare spending in numerous countries is likely to boost demand for face shields throughout the predicted period. Furthermore, growing healthcare infrastructure in emerging countries, along with an increasing number of individuals seeking healthcare services, is expected to support market growth throughout the forecast period.

Face shields are commonly utilized in a variety of healthcare settings. It has played an important role in safeguarding healthcare staff and patients from cross-contamination and pathogen transmission, it has been made essential and recommended throughout the healthcare industry. The growing healthcare industry is expected to drive the face shields market demand over the forecast period.

Request a free sample copy or view report summary: Face Shields Market Report

Face Shields Market Report Highlights

• Rising demand for face shields in the healthcare sector amid coronavirus outbreaks coupled with the increasing awareness about workplace safety in various end-use industries is anticipated to create opportunities for face shield manufacturers over the forecast period
• The construction segment accounted for 13.8% of the global revenue in 2021 owing to rising adoption of face shields on account of increasing construction activities post relaxation from lockdowns
• The healthcare face shield segment accounted for 27.4% of the global revenue share in 2021 and is predicted to expand at the fastest rate due to the rising usage of face shields by personnel working in medical institutions
• The chemical industry application sector is expected to have a CAGR of 7.6%over the forecast period owing to an increase in the work-place fatal injuries in the chemical industry is expected to create opportunities for the face shield manufacturers over the forecast period
• In March 2020, Honeywell International Inc. announced the expansion of manufacturing capabilities in Phoenix, Arizona, U.S. to manufacture N95 face masks for supporting the U.S. government’s response to the Covid-19

Access Press Release@ https://www.grandviewresearch.com/press-release/global-face-shield-market

Face Shields Market Segmentation

Grand View Research has segmented the global face shields market on the basis of product, end-use, and region:

Face Shields Product Outlook (Revenue, USD Million, 2017 - 2030)

• Full Face Shield
• Half Face Shield

Face Shields End-use Outlook (Revenue, USD Million, 2017 - 2030)

• Healthcare
• Construction
• Chemical
• Oil & Gas
• Manufacturing
• Others

Face Shields Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK.
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Indonesia
  • Australia
  • Thailand
  • Malaysia
• Central & South America
  • Brazil
  • Argentina
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • South Africa

List of Key Players of Face Shields Market

• 3M
• Honeywell International
• ALPHAPROTECH
• CASCO BAY MOLDING
• Kimberly-Clark.
• Lakeland Inc.
• MSA
• Aspen Surgical
• Prestige Ameritech
• Pyramex Safety Products, LLC
• Sanax Protective Products
• Key Surgical
• KARAM
• Medline Industries, Inc.
• Gateway Safety, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Medical Foods For Orphan Diseases Market Poised to Expand at a Robust Pace Over 2030: Grand View Research Inc.

 Medical Foods For Orphan Diseases Market Growth & Trends

The global medical foods for orphan diseases market size is expected to reach USD 1.9 billion by 2030. It is expected to expand at a CAGR of 5.5% from 2023 to 2030, according to a new report by Grand View Research, Inc. The major factors contributing to the industry’s growth are the growing prevalence of orphan diseases and increasing awareness about such rare conditions. Moreover, rising government initiatives for early screening and increasing initiatives by key players to develop products that cater to such niche segments also spell a promising horizon of growth.

Special medical nutritional requirements are needed for a variety of rare diseases in order to prevent major disabilities and allow normal growth in children and adults. Conditions like food protein-induced maple syrup urine disease, short bowel syndrome, and others, require special dietary requirements in order to maintain robust health. The growing awareness of such rare conditions and increased efficacy of diet plans also promise more avenues for growth.

Medical foods are expensive and may or may not be covered under health insurance. Since the FDA does not classify medicinal foods as drugs, many insurance plans do not cover them. This can impede market expansion over the forecast period.

Unlike other industries, COVID-19 had a positive impact on market growth. The increased awareness about immunity and healthy foods led to a significant rise in the adoption rate of clinical foods. In the year 2020, consumers opted for much healthier diets encompassing nutritional support and dietetic care as compared to the year 2019.

The oral segment dominated the market with a revenue share of over 69.5% in 2022. The oral route for medicinal foods remains the most convenient, and hassle-free. Hence, it remains the most preferred route for consumers globally and oral products are easily available. The expanding production of oral goods in the form of tablets, powder, and pre-thickened products also remains a prominent driver of growth.

The powder segment accounted for the largest revenue share of over 35.4% in 2022. Easy commercial availability of medicinal foods in powdered form is largely responsible for the segment's expansion. Additionally, powered forms of products are simple to use and hence widely preferred by pediatric and geriatric patients suffering from various rare diseases, which continues to drive the segment's expansion.

The institutional sales channel accounted for the largest revenue share of over 41.2% in 2022. The segment includes home care settings, hospitals, and disability facilities. The online sales segment is anticipated to expand at the fastest rate over the forecast period. Due to the convenience, these sales channel provides, more people choose to buy medicinal foods online.

Request a free sample copy or view report summary: Medical Foods For Orphan Diseases Market Report

Medical Foods For Orphan Diseases Market Report Highlights

• The market size was valued at USD 1.2 billion in 2022 and is expected to grow at a CAGR of 5.5% from 2022 to 2030. Increasing prevalence of rare diseases, healthcare expenditure, early screening, and awareness about rare diseases are some key factors that propel the growth
• The oral segment held the dominant revenue share of over 69.5% in 2022. However, the enteral route of the administration segment is expected to showcase the fastest growth over the forecast years. Key players are highly focused on developing technologically advanced enteral feeding devices which are anticipated to play a major role in this segment’s growth.
• The powder segment accounted for the largest revenue share of over 35.4% in 2022. However, the liquid segment is expected to grow at the fastest CAGR over the forecast period. The rising adoption rate of liquid formulations by pediatric and geriatric consumers, as the intake of solid formulations is restricted or unfeasible is the major reason that fuels the segment’s growth
• The institutional sales channel accounted for the largest revenue share of over 41.2% in 2022. The increasing number of patient visits to hospitals and other healthcare centers for the diagnosis and treatment of different orphan disorders continues to propel the growth of the segment
• The others segment accounted for the largest revenue share of over 36.5% in 2022. The increasing number of hypoallergenic product launches and easy commercial availability of such products in various formulations further boost the segment’s growth. However, FPIES condition is expected to showcase the fastest CAGR over the forecast period
• In 2022, North America held the largest revenue share of over 30.6%. Asia Pacific is anticipated to be the fastest-growing regional market over the forecast period. Increasing penetration rate, awareness, growing use of medical foods, and several key government initiatives remain the cornerstone of its growth

Access Press Release@ https://www.grandviewresearch.com/press-release/global-medical-foods-for-orphan-diseases-market

Medical Foods For Orphan Diseases Market Segmentation

Grand View Research, Inc. has segmented the global medical foods for orphan diseases market based on the route of administration, product, application, sales channel, and region:

Medical Foods For Orphan Diseases Route of Administration Outlook (Revenue, USD Million, 2016 - 2030)

• Oral
• Enteral

Medical Foods For Orphan Diseases Product Outlook (Revenue, USD Million, 2016 - 2030)

• Pills
• Powder
• Liquid
• Others

Medical Foods For Orphan Diseases Application Outlook (Revenue, USD Million, 2016 - 2030)

• Phenylketonuria
• Tyrosinemia
• Eosinophilic esophagitis
• FPIES
• MSUD
• Homocystinuria
• Others

Medical Foods For Orphan Diseases Sales Channel Outlook (Revenue, USD Million, 2016 - 2030)

• Online Sales
• Institutional Sales
• Retail Sales

Medical Foods For Orphan Diseases Regional Outlook (Revenue, USD Million, 2016 - 2030)

• North America
  • The U.S.
  • Canada
• Europe
  • UK.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Singapore
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • Saudi Arabia
  • Africa
  • UAE

List of Key Players in the Medical Foods For Orphan Diseases Market

• Nestle
• Danone
• Abbott
• Mead Johnson & Company, LLC
• Relief Therapeutics
• Solace Nutrition
• Ajinomoto Cambrooke, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

U.S. Pharmaceutical Sterility Testing Market to Reflect a Holistic Expansion During 2022 to 2030: Grand View Research Inc.

 U.S. Pharmaceutical Sterility Testing Market Growth & Trends

The U.S. pharmaceutical sterility testing market size is anticipated to reach USD 1.18 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 10.9% from 2022 to 2030. Supportive government investment in the healthcare industry, increasing R&D activities, and growing demand for new therapeutics in the country are the key factors driving the growth. The majority of clinical trials worldwide are performed in the U.S. alone.

According to ClinicalTrials.gov, as of October 2022, over 31% of global clinical trials were registered in the U.S. alone. This is due to the significant number of initiatives taken by public organizations in the country to support R&D activities. The presence of technologically advanced infrastructure and an increase in R&D investment by pharmaceutical companies are also supporting clinical trials in the country. This is expected to improve the number of new medications and medical devices in the coming years in the U.S. and support the market in the post-pandemic period.

The government is keen on bringing down healthcare costs, which is anticipated to encourage the U.S. Food and Drug Administration (FDA) to promote the fast approval of generic pharmaceuticals. Faster approvals drive the need for newer sterility testing methods. This is anticipated to encourage market participants to spend more on sterility solutions and, in turn, expand the market. With an increasing demand for drugs, companies are launching new drugs with different routes of administration, dosage, and indication. These launches require thorough sterility testing and, thus, are anticipated to drive the industry’s growth.

The majority of pharmaceutical companies, biopharmaceutical companies, CROs, and CMOs are headquartered in the U.S. Companies such as Catalent, Inc., Pfizer Inc., AbbVie, Merck; Co. Johnson & Johnson, and Abbott are located in the U.S. The high number of pharmaceutical companies, biopharmaceutical companies, CMOs, and CROs located in the U.S. contributes to the high demand for sterility testing of pharmaceuticals, thus supporting the market growth.

The country suffers from a high burden of cancer. Due to this, government-based research institutes in the U.S. are constantly trying to improve cancer research funding in the country. For instance, in May 2022, the American Institute of Cancer Research stated that it had funded more than USD 110 million in cancer research in 2022, and it intends to fund more in the coming years to reduce the burden of cancer. Such initiatives are expected to increase the number of new medications for cancer in the coming years, thus increasing the demand for sterility testing of cancer drugs in the post-pandemic period.

Request a free sample copy or view report summary: U.S. Pharmaceutical Sterility Testing Market Report

U.S. Pharmaceutical Sterility Testing Market Report Highlights

• Outsourcing emerged as the largest segment in 2021 with a share of 45.2%, as pharmaceutical and biopharmaceutical companies are trying to reduce expenses and hence outsourcing non-core functions such as sterility testing
• The sterility testing segment, by test type is expected to witness the fastest CAGR of 11.3% across the forecast as these tests are recommended by regulatory authorities such as the USFDA
• Based on product type, the kits and reagents segment held the largest share of 59.7% in 2021, due to the high consumption of these products in sterility testing
• The biopharmaceuticals segment by the sample is expected to grow at the fastest rate of 11.2% CAGR across the forecast owing to the growing demand for biologics such as vaccines, and monoclonal antibodies in the country for treating chronic and infectious diseases
• Based on end-use, the pharmaceutical companies accounted for the largest share of 42.9% in 2021, owing to the growing number of drug recalls due to lack of sterility, thus supporting segment growth

Access Press Release@ https://www.grandviewresearch.com/press-release/us-pharmaceutical-sterility-testing-market-analysis

U.S. Pharmaceutical Sterility Testing Market Segmentation

Grand View Research, Inc. has segmented the U.S. pharmaceutical sterility testing market based on type, product, test type, sample, and end-use:

U.S. Pharmaceutical Sterility Testing Type Outlook (Revenue, USD Million, 2018 - 2030)

• In-house
• Outsourcing

U.S. Pharmaceutical Sterility Testing Product Type Outlook (Revenue, USD Million, 2018 - 2030)

• Kits and Reagents
• Instruments
• Service

U.S. Pharmaceutical Sterility Testing Test Type Outlook (Revenue, USD Million, 2018 - 2030)

• Sterility Testing
• Membrane Filtration
• Direct Inoculation
• Product Flush
• Bioburden Testing
• Bacterial Endotoxin Testing

U.S. Pharmaceutical Sterility Testing Sample Outlook (Revenue, USD Million, 2018 - 2030)

• Pharmaceuticals
• Medical Devices
• Biopharmaceuticals

U.S. Pharmaceutical Sterility Testing End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Compounding Pharmacies
• Medical Devices Companies
• Pharmaceutical Companies
• Others

List of Key Players in the Pharmaceutical Sterility Testing Market

• SGS SA
• Laboratory Corporation of America Holdings
• Boston Analytical
• Charles River Laboratories
• Pacific Biolabs
• STERIS
• Pace Analytical
• Nelson Laboratories, LLC
• Infinity Laboratories
• Thermo Fisher Scientific, Inc

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

U.S. Residential Solar PV Market Industry Analysis Comparing Industry Prospects And Challenges Of Investing

 

U.S. Residential Solar PV Market Growth & Trends

The U.S. residential solar PV market size is expected to reach USD 44.77 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 15.3% from 2023 to 2030. Increasing demand for clean and renewable energy production coupled with stringent regulations regarding carbon emissions is expected to boost growth during the forecast period.

Governments across the world have started to adopt solar energy for power production due to it being clean and renewable. Many countries have set targets to reduce their carbon emissions and reduce reliance on conventional energy sources by promoting the use of solar energy for power production. The economies of scale achieved due to this increased demand have in turn decreased the cost of the components making solar energy system installation viable on a smaller scale.

The increasing energy need for emerging states in the U.S. such as California, Texas, and Arizona is expected to positively impact the residential solar PV industry. The decline in the price of solar energy system components has increased the viability of solar energy system installations in the residential sector. The new construction segment in the U.S. Residential Solar PV market is expected to grow significantly in the forecast period owing to the increasing adoption of government regulations to mandate the installation of solar PV into new construction homes.

States such as California and Texas are expected to boost the industry's growth over the forecast period owing to the high amount of investments for solar PV in the States and the increasing energy requirement boosting the demand for solar PV in the States. The price of the components in the solar PV systems market has been declining consistently for the last 10 years and this trend is expected to continue for the forecast period, in turn increasing the demand in the residential sector increasing the demand.

Request a free sample copy or view report summary: U.S. Residential Solar PV Market Report

U.S Residential Solar PV Market Report Highlights

• Various state governments have set targets to reduce carbon emissions and have implemented policies to promote the adoption of solar PV systems in the residential sector which is expected to boost the solar PV demand over the forecast period
• The retrofit segment accounted for about 74.12% of the market share in 2022. Solar PV is the most complex component in solar energy systems and received the highest investments for R&D
• California is projected to grow at a substantial CAGR throughout the forecast period. The rest of the U.S. is expected to account for the maximum share
• Solar power accounted for a 3.4% share of the total electricity generation mix in the U.S. in 2022

Access Press Release@ https://www.grandviewresearch.com/press-release/us-residential-solar-pv-market-analysis

U.S Residential Solar PV Market Segmentation

Grand View Research has segmented U.S. residential solar PV market based on construction and state:

U.S Residential Solar PV Construction Outlook (Capacity, MW, Revenue, USD Million, 2018 - 2030)

• Retrofit
• New Construction

U.S Residential Solar PV State Outlook (Capacity, MW, Revenue, USD Million, 2018 - 2030)

• California
• New York
• Arizona
• New Jersey
• Massachusetts
• Texas
• Rest of U.S.

List of Key Players of U.S. Residential Solar PV Market

• Tesla
• SunPower Corp.
• Sunrun
• Trinity Solar Inc.
• Sungevity
• Momentum Solar
• SPI Energy Co. Ltd.
• Ace Solar
• Sunlux
• Titan Solar Power

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Life Science Tools Market Insights Business Opportunities, Current Trends And Forecast 2030: Grand View Research Inc.

 Life Science Tools Market Growth & Trends

The global life science tools market size is expected to reach USD 330.69 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 10.8% from 2023 to 2030. This growth can be attributed to a rise in government funding for life science technologies, demand for cell and gene therapies, an increase in the adoption of biopharmaceuticals, and growing competition among prominent companies in the market.

The exponential rise of COVID-19 cases globally requires rapid diagnosis for containment of the spread of infectious disease, which boosted the demand for life science tools during the pandemic and had a positive impact on the market. Rapid diagnosis of the infection, effective treatments, and preventative plans are essential for the management of cases during the COVID-19 pandemic. The current race for the development of cost-effective point-of-contact test kits and efficient laboratory methodologies for confirmation of SARS-CoV-2 infection has driven a new frontier of diagnostic innovation. During this pandemic, the U.S. FDA granted Emergency Use Authorizations (EUAs) to several diagnostic tests to make them rapidly and easily available for use. For example, in May 2022, the U.S. FDA granted a EUA to ID NOW COVID-19 2.0, a rapid in-vitro diagnostic test by Abbott Diagnostics Scarborough, Inc. Moreover, a wide range of commercial COVID-19 tests is available in the marketplace, which will further add to revenue generation.

Additionally, the life science tools industry is expanding based on the increasing investments by the government for the advancement of research and technologies. Organizations such as The National Human Genome Research Institute (NHGRI) and the National Institutes of Health (NIH) are actively funding various life science projects. For instance, the NIH funded USD 25 million for the ‘4D Nucleome Program’, which aims to understand gene regulation and cellular expression via the nuclear organization. Moreover, the U.S. government has funded several life sciences companies for R&D purposes. For instance, the Biomedical Advanced Research and Development Authority (BARDA) has planned to make awards worth USD 750,000 to facilitate the development of innovative technologies in the healthcare sector. Thus, the increase in government funding for life science research as well as technologies is expected to drive the market in the coming years.

Key players are also contributing to the growth of the market by providing advanced tools and techniques. Furthermore, companies are introducing new automated solutions in the market, which, in turn, provide lucrative opportunities for market growth. For instance, in February 2022, Covaris, LLC. announced the launch of truXTRAC FFPE Total NA Auto 96 Kit, a fully automated workflow comprising all necessary accessories, consumables, and reagents. This automated kit is powered by Adaptive Focused Acoustics (AFA) technology that allows both purification and extraction of RNA & DNA for FFPE (formalin fixed paraffin embedded) samples in 5 hours. The introduction of innovative solutions is expected to drive the market in the near future.

Request a free sample copy or view report summary: Life Science Tools Market Report

Life Science Tools Market Report Highlights

• By technology, cell biology technology accounted for the largest share in 2022. The introduction of novel technologies for the usage and adoption of stem cells, CAR T-cells, TCR T-cells, NK T-cells, and other cell therapies is expected to boost revenue generation in this segment
• By product, the cell culture systems and 3D cell culture segment held the largest share in 2022. Cell biology is gaining popularity across multiple aspects in the life science industry, which is contributing significantly to the revenue generated by this segment
• By end-use, the healthcare segment generated the highest revenue in 2022. The rise in adoption of proteomic and genomic workflows in clinics, hospitals, and diagnostic laboratories for the treatment and diagnosis of several clinically presented abnormalities is anticipated to drive the market
• North America accounted for the largest revenue share in 2022. The rapid adoption of genomics, proteomics, oncology, and diagnostic screening in the region has contributed to regional growth. In addition, a number of major market players are continuously engaged in the development of advanced tools for life science research in this region
• Asia Pacific is expected to grow at the highest rate over the projected period. Investments by global companies in this region to utilize the untapped avenue and lucrative opportunities will drive the regional market

Access Press Release@ https://www.grandviewresearch.com/press-release/global-life-science-tools-market

Life Science Tools Market Segmentation

Grand View Research has segmented the global life science tools market on the basis of technology, product, end-use, and region:

Life Science Tools Technology Outlook (Revenue, USD Billion, 2018 - 2030)

• Genomic Technology
• Proteomics Technology
• Cell Biology Technology
• Other Analytical & Sample Preparation Technology
• Lab Supplies & Technologies

Life Science Tools Product Outlook (Revenue, USD Billion, 2018 - 2030)

• Cell Culture Systems & 3D Cell Culture
  • Instruments
  • Consumables
  • Cell & Tissue Culture Services
• Liquid Chromatography
  • Instruments
  • Consumables
  • Services
• Mass Spectrometry
  • Instruments
  • Consumables
  • Services
• Flow Cytometry
  • Instruments
  • Consumables
  • Services
• Cloning & Genome Engineering
  • Kits, Reagents, and Consumables
  • Services
• Microscopy & Electron Microscopy
  • Instruments
  • Consumables
  • Services
• Next Generation Sequencing
  • Instruments
  • Consumables
  • Services
• PCR & qPCR
  • Instruments
  • Consumables
  • Services
• Nucleic Acid Preparation
  • Instruments
  • Consumables
  • Services
• Nucleic Acid Microarray
  • Instruments
  • Consumables
  • Services
• Sanger Sequencing
  • Instruments
  • Consumables
  • Services
• Transfection Devices & Gene Delivery Technologies
  • Equipment
  • Reagents
• NMR
  • Instruments
  • Consumables
  • Services
• Other Separation Technologies
  • Instruments
  • Consumables
  • Services
• Other Products & Services
  • Antibodies
  • General Supplies
  • Others
    • Instruments
    • Consumables
    • Services

Life Science Tools End-use Outlook (Revenue, USD Billion, 2018 - 2030)

• Government & Academic
• Biopharmaceutical Company
• Healthcare
• Industrial Applications
• Others

Life Science Tools Regional Outlook (Revenue, USD Billion, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Switzerland
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
  • Singapore
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players of Life Science Tools Market

• Agilent Technologies, Inc.
• Becton, Dickinson and Company
• Hoffmann-La Roche Ltd.
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• Illumina, Inc.
• Thermo Fisher Scientific, Inc.
• QIAGEN N.V.
• Merck KGaA
• Shimadzu Corporation
• Hitachi, Ltd.
• Bruker Corporation
• Oxford Instruments plc
• Zeiss International

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.